LatinNews Daily - 07 August 2025

*Peru’s President Dina Boluarte has presented a portfolio of investment projects worth US$17.3bn to Japanese business representatives during an official visit to Tokyo. According to a Peruvian government press release, during a meeting of the Peruvian-Japanese business council (Cepeja), Boluarte said that Peru is offering a portfolio comprising over 28 projects to be awarded throughout 2025, worth over US$8.2bn, aimed at key sectors such as health, sanitation, education, transportation, telecommunications, infrastructure, mining, hydrocarbons, irrigation, and others. She said that an additional 48 projects are scheduled to be awarded in 2026, for a total value exceeding US$9.1bn. Peru’s state news agency Andina reported that, at the same meeting, Peru’s minister of foreign trade and tourism, Desilú León, who was part of the high-level delegation, also presented commercial and industrial opportunities valued at over US$1.1bn, a portfolio which included agricultural and fishery products, and light manufacturing. The Andina report cites León as saying that Peru has a network of 23 free trade agreements covering 82% of global GDP, and underlining that Peru is an active member of the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP), which “enhances preferential access for Peruvian products to the Asian market”. It also cites her as saying that Peru and Japan “maintain a solid and strategic trade relationship, consolidated through the strategic partnership agreement (AAE), signed in May 2011 and in force since March 2012”. According to the same Andina report, last year, trade between the two countries reached a “record high” of over US$4.3bn. Peruvian exports totalled US$3.4bn with “sustained growth in key sectors such as agroindustry and fisheries”.

End of preview - This article contains approximately 276 words.

Subscribers: Log in now to read the full article

Not a Subscriber?

Choose from one of the following options

• Subscribe
• Sign up for a one-time, 14-day trial